BCS_Blog_DTOP_BelowTitle_336x280

Bye Bye, Diabetes: 100 Years With This Vaccine, and We’re Finally Learning Its True Capabilities

A decades-old vaccine might have something to offer people with type 1 diabetes!

A research team at Massachusetts General Hospital is about to begin a five-year-long trial to determine whether BCG can be used in the treatment of diabetes. The vaccine, which is used to prevent tuberculosis, has demonstrated the ability to not only treat type 1 diabetes, but to reverse it!

The five-year trial will include 150 participants who will receive two injections within four months of each other. Over the following four years, they will be given an additional injection annually. In pre-trial studies, BCG was shown to destroy the blood cells that attack the pancreas and prevent it from making insulin. Moreover, the vaccine actually increased the number of positive blood cells that repress diabetes.

Check out the video below to learn more about the BCG vaccine.

Proper BCS breastcancersite_abovevideo
Medianet BCS
RevContent BCS – Desktop
Proper BCS breastcancersite_belowcontent
Garrett Dennert resides in West Michigan. When he isn’t writing (or editing), you can find him outside, riding a bike, reading a book, or just plain running. Other interests include sports (of any kind), music (again, any kind) and cinema (a bit pickier here).